October 23, 2023 Experience Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant We are advising Roche on the acquisition
October 12, 2023 Experience Genetron $126 million going-private transaction We are separately advising Genetron and the special committee of its board on the transaction
September 5, 2023 Experience PracticeTek merger with Integrated Practice Solutions and related financing We advised Lightyear Capital and PracticeTek on the transaction to form a leading U.S. retail healthcare solutions provider
August 28, 2023 Experience Abcam $5.7 billion acquisition by Danaher We advised financial advisers to Abcam on the transaction
August 15, 2023 Experience SSI Strategy acquisition of NDA Group We advised SSI Strategy on the acquisition
August 2, 2023 Experience Allurion Technologies merger with Compute Health Acquisition We advised the capital markets adviser on the de-SPAC transaction
July 28, 2023 Experience Immedica Pharma acquisition of pegzilarginase assets from Aeglea We advised Immedica on the transaction
June 28, 2023 Experience Centogene strategic collaboration with Lifera We are advising Centogene on its joint venture with and convertible debt investment by Lifera
May 17, 2023 Experience Forbion European Acquisition combination with enGene We are advising Forbion European Acquisition on its de-SPAC transaction
May 12, 2023 Experience GSK exclusive licensing agreement with Scynexis We advised GSK on the transaction